Avai Bio, Inc. (AVAI)

Price$0.1150Cached quote
AVAIOTC
Loading local price history

Financial charts

Total cash / debt

CashTotal debt

Financial statements

8 annual periodsNewest to oldest
20262025202420232022202120202019
Revenue$0$0$0$276,324——$1.4M—
Gross profit——$0−$40,453−$210,794−$16,536−$256,334$0
Gross margin———−14.64%——−17.86%—
Research & development$15,000$0————$27,040$0
Operating expenses$1.5M$1.5M$2.1M$323,131$553,920$287,188$325,927$78,225
Operating income−$1.7M−$1.1M−$2.1M−$348,933$126,521$302,292$69,593−$78,225
Operating margin———−126.28%——4.85%—
EBITDA−$1.7M−$1.1M−$2.1M−$325,516——$108,695−$73,423
EBITDA margin———−117.80%——7.58%—
Net income−$1.7M−$1.1M−$2.1M−$348,933−$126,521−$302,292−$69,593−$78,225
Net profit margin———−126.28%——−4.85%—
Basic EPSper basic share-$0.01-$0.01-$0.02$0.00$0.00$0.00$0.00$0.00
Diluted EPSper diluted share-$0.01-$0.01-$0.02$0.00——$0.00$0.00

Owners

Reported shareholders

Ownership data is not available for this listing yet.

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.

Community posts

It’s quiet here.

No posts about AVAI yet. Start the conversation.

Write the first post